Drawing for BEMRIST

USPTO serial 79227117

BEMRIST

Reviewed by CopyMark Law Group

Reg. 5537945Status 709
Filing date
Status date
Registration date
Aug 14, 2018
Examiner
CROWLEY, SEAN MICHAEL
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with BEMRIST?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Maury M. Tepper, III

Maury M. Tepper, III Tepper & Eyster, PLLC3724 Benson DriveRALEIGH, NC 27609UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthmaSECTION 71 - CANCELLED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 20, 2026Further Decision Processed by IB
May 20, 2026XXSSGENERIC MADRID TRANSACTION SENT TO IB
May 19, 2026INNAINVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
May 19, 2026XXCRGENERIC MADRID TRANSACTION CREATED
Oct 28, 2025INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Feb 28, 2025C71TCANCELLED SECTION 71
Aug 14, 2023REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Dec 21, 2018FINVFINAL DECISION TRANSACTION PROCESSED BY IB
Dec 1, 2018FICSFINAL DISPOSITION NOTICE SENT TO IB
Dec 1, 2018FIMPFINAL DISPOSITION PROCESSED
Nov 14, 2018FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 21, 2018GPNXNOTIFICATION PROCESSED BY IB
Aug 14, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 29, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 29, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 16, 2018OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 16, 2018OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
May 9, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 24, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Apr 24, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Apr 24, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 19, 2018ALIEASSIGNED TO LIE
Apr 13, 2018RFNTREFUSAL PROCESSED BY IB
Apr 11, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 3, 2018ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 3, 2018REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 15, 2018RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 15, 2018RFRRREFUSAL PROCESSED BY MPU
Mar 9, 2018RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 8, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 3, 2018MAFRAPPLICATION FILING RECEIPT MAILED
Feb 27, 2018DOCKASSIGNED TO EXAMINER
Feb 27, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 20, 2018LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED
Feb 15, 2018SDRCSN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

Frequently asked questions

Related guidance